United States:
FDA Extends Comment Period For Rare Pediatric Disease Priority Review Vouchers
22 January 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the December 24, 2014, Federal Register,
FDA announced that it has extended the comment period regarding the
Agency's implementation of the Rare Pediatric Disease Priority
Review Vouchers Program. Comments now due February 16,
2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
